◄ back to all posts
Financial data and stock pages provided by
Fintel.io
Will “Go Crazy” Drive The Bear Out Of Hibernation?
Feb 24, 2021
◄ back to all posts
LCI: Lannett Co., Inc. Stock
Written by | Jul 6, 2018
Print FriendlySIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 250.89 |
| Enterprise Value ($M) | 875.09 |
| Book Value ($M) | 129.26 |
| Book Value / Share | 3.12 |
| Price / Book | 1.95 |
| NCAV ($M) | -363.21 |
| NCAV / Share | -8.77 |
| Price / NCAV | -0.70 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.03 |
| Return on Assets (ROA) | -0.03 |
| Return on Equity (ROE) | -0.10 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 1.74 |
| Current Ratio | 2.49 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 407.80 |
| Assets | 900.27 |
| Liabilities | 771.01 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 19.56 |
| Net Income | -33.37 |
| Earnings Per Share Diluted | -0.86 |
| Earnings Per Share Basic | -0.86 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 116.01 |
| Cash from Investing | -40.00 |
| Cash from Financing | -40.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | D. E. Shaw & Co, L.p. | 4.50 | -44.70 | |
| 13G/A | Lsv Asset Management | 4.54 | -9.80 | |
| 13G/A | Vanguard Group Inc | 5.53 | -2.32 | |
| 13G/A | Highbridge Capital Management Llc | 5.32 | 9.98 | |
| 13G/A | BlackRock Inc. | 12.60 | 0.00 | |
| 13G/A | Jpmorgan Chase & Co | 8.30 | 26.49 | |
| 13G/A | Mintbroker International, Ltd. | 0.00 | -100.00 | |
| 13G/A | Flynn James E | 0.00 | -100.00 | |
| 13G/A | Snow Capital Management Lp | 0.90 | -87.92 | |
| 13G/A | Invesco Ltd. | 2.10 | -59.22 | |
| 13G | Ucb S.a. | 6.40 | ||
| 13G/A | Broadfin Capital, LLC | 3.80 | ||
| 13D/A | Farber Properties Group, LLC | 14.00 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| Quarterly Report – 10-Q | ||
| Quarterly Report – 10-Q | ||
| Annual Report – 10-K | ||
| Quarterly Report – 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 59,564 | 441,100 | 13.50 | |
| 56,540 | 624,746 | 9.05 | |
| 47,262 | 505,164 | 9.36 | |
| 70,669 | 631,400 | 11.19 | |
| 61,619 | 580,506 | 10.61 | |
(click for more detail) |
|||
(click for list of largest short owners) |
|||
| Similar Companies | |
|---|---|
| GSK – GlaxoSmithKline plc | HSP – Hospira |
| JNJ – Johnson & Johnson | LLY – Eli Lilly & Co. |
| MRK – Merck & Co., Inc. |
Financial data and stock pages provided by
Fintel.io
2018/07/06
Also Read
